Stable isotope methodology for kinetic studies of interconversion of cortisol and cortisone in a human subject

被引:17
作者
Kasuya, Y [1 ]
Ishimaru, H [1 ]
Shibasaki, H [1 ]
Furuta, T [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Med Chem & Clin Pharm, Hachioji, Tokyo 19203, Japan
关键词
kinetic analysis; deuterium-labeled cortisol; deuterium-labeled cortisone; gas chromatography mass spectrometry;
D O I
10.1016/S0039-128X(97)00102-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral administration of 5 mg each of deuterium-labeled cortisol ([1,1,19,19,19-H-2(5)]cortisol, cortisol-d(5)) and cortisone-d(5) ([1,1,19,19,19-H-2(5)]cortisone) to a human subject on two different occasions four weeks apart provided a useful means of characterizing the kinetics of the interconversion of cortisol and cortisone. From the data on plasma concentration measurements of cortisol-d(5), cortisone-d(5), endogenous cortisol and endogenous cortisone by gas chromatography-mass spectrometry, it was demonstrated that (I) the plasma concentration ratio of cortisone-d(5) to cortisol-d(5) approached a plateau 4-5 h following either the cortisol-d(5) or cortisone-d(5) administration and the plateau values for the cortisone-d(5) and cortisol-d(5) administration were almost identical (about 0.43) and (2) dosing with only 5 mg of the deuterium-labeled steroids suppressed the plasma concentrations of endogenous cortisol and cortisone. (C) 1998 by Elsevier Science Inc.
引用
收藏
页码:122 / 129
页数:8
相关论文
共 32 条
  • [1] AANDERUD S, 1981, ACTA MED SCAND, V210, P157
  • [2] EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS
    AGARWAL, AK
    TUSIELUNA, MT
    MONDER, C
    WHITE, PC
    [J]. MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) : 1827 - 1832
  • [3] SERUM CORTISOL APPEARANCE-DISAPPEARANCE IN ADRENAL INSUFFICIENCY AFTER ORAL CORTISONE-ACETATE
    BARBATO, AL
    LANDAU, RL
    [J]. ACTA ENDOCRINOLOGICA, 1977, 84 (03): : 600 - 604
  • [4] PHARMACOKINETIC INTERPRETATION OF PLASMA-CORTISOL AND CORTISONE CONCENTRATIONS FOLLOWING A SINGLE ORAL-ADMINISTRATION OF CORTISONE-ACETATE TO HUMAN-SUBJECTS
    COLBURN, WA
    DISANTO, AR
    STUBBS, SS
    MONOVICH, RE
    DESANTE, KA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (07) : 428 - 436
  • [5] DORFMAN RI, 1965, METABOLISM STEROID H, P605
  • [6] 11 beta-hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects
    Edwards, CRW
    Benediktsson, R
    Lindsay, RS
    Seckl, JR
    [J]. STEROIDS, 1996, 61 (04) : 263 - 269
  • [7] FARISS RL, 1978, J CLIN EDOCRINOL MET, V33, P52
  • [8] PHARMACOLOGY OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE
    FREY, FJ
    ESCHER, G
    FREY, BM
    [J]. STEROIDS, 1994, 59 (02) : 74 - 79
  • [9] MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED
    FUNDER, JW
    PEARCE, PT
    SMITH, R
    SMITH, AI
    [J]. SCIENCE, 1988, 242 (4878) : 583 - 585
  • [10] APPARENT MINERALOCORTICOID EXCESS
    FUNDER, JW
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1995, 24 (03) : 613 - &